Cargando…
Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogenous disease. Identifying more precise and individual survival prognostic models are still needed. This study aimed to develop a predictive nomogram and a web-based survival rate calculator that can dynamically predict th...
Autores principales: | Zhong, Qiaofeng, Shi, Yuankai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841349/ https://www.ncbi.nlm.nih.gov/pubmed/33520698 http://dx.doi.org/10.3389/fonc.2020.582567 |
Ejemplares similares
-
Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma
por: Roh, Jin, et al.
Publicado: (2020) -
Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma
por: Zhang, Bingxin, et al.
Publicado: (2023) -
Development and validation of platelet-to-albumin ratio as a clinical predictor for diffuse large B-cell lymphoma
por: Wang, Jinghan, et al.
Publicado: (2023) -
Development and validation of nomograms by radiomic features on ultrasound imaging for predicting overall survival in patients with primary nodal diffuse large B-cell lymphoma
por: Deng, Hongyan, et al.
Publicado: (2022) -
Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study
por: Shi, Xue, et al.
Publicado: (2021)